Abstract:ObjectiveTo investigate the expression level of neutrophil extracellular traps (NET) in the peripheral blood and liver tissue of primary biliary cholangitis (PBC) patients and its correlation with clinical biochemical parameters. MethodsA total of 24 PBC patients who were admitted to Renji Hospital, Shanghai Jiao Tong University School of Medicine, from August 2016 to August 2020 were enrolled, as well as 8 patients with primary sclerosing cholangitis (PSC) and 19 patients with autoimmune hepatitis (AIH) matched for age, and 19 healthy individuals were enrolled as healthy control group (HC group). The serum level of myeloperoxidase (MPO) was measured, and its correlation with clinical indices were analyzed. Immunofluorescence assay was used to measure the expression of NET in the liver of PBC patients, and an in vitro experiment was to compare the ability of peripheral blood neutrophils to produce NET between PBC patients and healthy controls. Normally distributed continuous data were expressed as mean±standard deviation, and the independent samples t-test was used for comparison between two groups; for the non-normally distributed continuous data expressed as M(P25-P75), the Kruskal-Wallis H test was used for comparison between multiple groups, and the Mann-Whitney U test was used for comparison between two groups. A correlation analysis was performed for MPO level and liver-related laboratory markers, and the Spearman’s correlation coefficient was calculated. ResultsThe serum level of MPO in the PBC group was increased to 811.21 (450.67-1 216.20) ng/mL, which was significantly higher than that in the AIH group ［468.58 (142.63-812.43) ng/mL］ and the HC group ［357.54 (203.52-811.21) ng/mL］ (P＜005), suggesting that there was a significant increase in the production of NET in peripheral blood of PBC patients. The PSC patients had a serum MPO level of 763.56 (489.59-1 633.14) ng/mL, which was significantly higher than that in the HC group (P＜0.05). MPO level was positively correlated with alkaline phosphatase (r=0.500, P＜0.05), gamma-glutamyl transpeptidase (r=0.426, P＜0.05), alanine aminotransferase (r=0.521, P＜0.05), and aspartate aminotransferase (r=0.547, P＜0.01). Confocal immunofluorescence showed colocalization of H3Cit and MPO in the liver of PBC patients. In vitro experiment showed that compared with the HC group, the PBC group had an increase in NET produced by peripheral blood neutrophils after in vitro stimulation and an increase in spontaneous production of NET. ConclusionThere is an increase in NET in peripheral blood and liver of PBC patients, and the content of peripheral blood NET is positively correlated with biochemical parameters of liver function. NET may become a novel biomarker for assessing the severity of PBC.

Neutrophil extracellular traps are associated with enhanced procoagulant activity in liver cirrhosis patients with portal vein thrombosis

Neutrophil extracellular traps induced by pro-inflammatory cytokines enhance procoagulant activity in NASH patients

Neutrophil extracellular traps induce intrahepatic thrombotic tendency and liver damage in cholestatic liver disease

GSDMD-Dependent Neutrophil Extracellular Traps Mediate Portal Vein Thrombosis and Associated Fibrosis in Cirrhosis

Neutrophil Extracellular Traps: Potential Thrombotic Markers and Therapeutic Targets in Colorectal Cancer

Neutrophil extracellular traps induced by activated platelets contribute to procoagulant activity in patients with colorectal cancer

Neutrophil extracellular traps formation may be involved in the association of propranolol with the development of portal vein thrombosis

Neutrophil extracellular traps promote thrombogenicity in cerebral venous sinus thrombosis

Neutrophil extracellular traps participate in the development of cancer-associated thrombosis in patients with gastric cancer

Neutrophil extracellular traps enhance procoagulant activity and thrombotic tendency in patients with obstructive jaundice

Neutrophil Extracellular Traps Participate in the Development of Gastric Cancer Associated Thrombosis

A Single Hospital Study on Portal Vein Thrombosis in Cirrhotic Patients - Clinical Characteristics & Risk Factors.

Platelet Activation is Upregulated in Cirrhotic Patients with Portal Vein Thrombosis.

Neutrophil extracellular traps exacerbate coagulation and endothelial damage in patients with essential hypertension and hyperhomocysteinemia

Potential contribution of the gut microbiota to the development of portal vein thrombosis in liver cirrhosis

Neutrophil extracellular traps induce a hypercoagulable state in glioma

Neutrophil Extracellular Traps Promote Hypercoagulability in Patients with Sepsis.

Novel insights into the development of portal vein thrombosis in cirrhosis patients

Risk factors for non-neoplastic portal vein thrombosis in patients with liver cirrhosis

A preliminary study of the role of neutrophil extracellular traps in patients with primary biliary cholangitis